Mark D. Salter & Naren Gunja. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
381
414
.
Jeanette L. Bertron, Mabel Seto & Craig W. Lindsley. (2018) DARK Classics in Chemical Neuroscience: Phencyclidine (PCP). ACS Chemical Neuroscience 9:10, pages 2459-2474.
Crossref
Thomas GeschwindeThomas Geschwinde. 2018. Rauschdrogen. Rauschdrogen
1
392
.
Felix Betzler & Tomislav Majić. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
683
699
.
James H. Ho & Paul I. Dargan. 2018. Critical Care Toxicology. Critical Care Toxicology
1
47
.
James H. Ho & Paul I. Dargan. 2017. Critical Care Toxicology. Critical Care Toxicology
1439
1484
.
Felix Betzler & Tomislav Majić. 2017. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
22
.
James H. Ho & Paul I. Dargan. 2016. Critical Care Toxicology. Critical Care Toxicology
1
46
.
Hamilton Morris & Jason Wallach. (2014) From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis 6:7-8, pages 614-632.
Crossref
Thomas GeschwindeThomas Geschwinde. 2013. Rauschdrogen. Rauschdrogen
1
320
.
F. Ivy Carroll, Anita H. Lewin, S. Wayne Mascarella, Herbert H. Seltzman & P. Anantha Reddy. (2012) Designer drugs: a medicinal chemistry perspective. Annals of the New York Academy of Sciences 1248:1, pages 18-38.
Crossref
Krishna C. Chimalakonda, Chris Hailey, Ryan Black, Allison Beekman, Rebecca Carlisle, Elizabeth Lowman-Smith, Heather Singletary, S. Michael Owens & Howard Hendrickson. (2010) Development and validation of an LC-MS/MS method for determination of phencyclidine in human serum and its application to human drug abuse cases. Analytical Methods 2:9, pages 1249.
Crossref
Joshua Gunn, Michael A. Evans & M. Scott Kriger. 2009. TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law. TASER® Conducted Electrical Weapons: Physiology, Pathology, and Law
327
345
.
John C.M. Brust. 2007. Aspects neurologiques de l'addiction. Aspects neurologiques de l'addiction
357
374
.
IVAN E. LIANG MD & EDWARD W. BOYER. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose
773
779
.
. 2007. Rauschdrogen. Rauschdrogen
7
294
.
John C.M. Brust. 2004. Neurological Aspects of Substance Abuse. Neurological Aspects of Substance Abuse
293
307
.
Thomas GeschwindeThomas Geschwinde. 2003. Rauschdrogen. Rauschdrogen
7
242
.
D Simpson, R A Braithwaite, D R Jarvie, M J Stewart, S Walker, I W Watson & B Widdop. (2016) Screening for Drugs of Abuse (II): Cannabinoids, Lysergic Acid Diethylamide, Buprenorphine, Methadone, Barbiturates, Benzodiazepines and other Drugs. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 34:5, pages 460-510.
Crossref
S. Sagratella, A. Pezzola, P. Popoli & A. Scotti de Carolis. (1992) Different capability ofn-methyl-d-aspartate antagonists to elicit EEG and behavioural phencyclidine-like effects in rats. Psychopharmacology 109:3, pages 277-282.
Crossref
Stephen H. Dinwiddie, Theodore Reich & C. Robert Cloninger. (1992) Patterns of lifetime drug use among intravenous drug users. Journal of Substance Abuse 4:1, pages 1-11.
Crossref
S. Sagratella, A. Scotti de Carolis, A. Pèzzola & P. Popoli. (1991) Behavioural and electroencephalographic interactions between haloperidol and PCP/sigma ligands in the rat. Psychopharmacology 105:4, pages 485-491.
Crossref
David A. Jerrard. (1990) “Designer drugs” — A current perspective. The Journal of Emergency Medicine 8:6, pages 733-741.
Crossref
Jay L. Schauben. (1990) Adulterants and Substitutes. Emergency Medicine Clinics of North America 8:3, pages 595-611.
Crossref
E. Bradford Baldridge & Howard A. Bessen. (1990) Phencyclidine. Emergency Medicine Clinics of North America 8:3, pages 541-550.
Crossref
Douglas J. Lanska & Mary Jo Lanska. (1988) PCP use among adolescent marijuana users. The Journal of Pediatrics 113:5, pages 950.
Crossref
John M. Herrera, Anna Okonek, Maria Parent, Swati Roy, Gordan MacLean & John Sramek. (1988) MMPI subtypes for chronic phencyclidine (PCP) abusers. Journal of Substance Abuse Treatment 5:3, pages 187-193.
Crossref
F.C.P. Law & S. Chakrabarth. (1985) Effects of cigarette smoke and 3-methylcholanthrene on the disposition of phencyclidine and its N-ethylamine analogue in the isolated perfused lung of rats. Toxicology 37:3-4, pages 275-284.
Crossref
Marilyn E. Carroll. (1984) Effects of pentobarbital and d-amphetamine on oral phencyclidine self-administration in rhesus monkeys. Pharmacology Biochemistry and Behavior 20:1, pages 137-143.
Crossref
S. Chakrabarti & F. C. P. Law. (1983) The dispositional kinetics of phencyclidine and itsN-ethylamine analogue in rats. European Journal of Drug Metabolism and Pharmacokinetics 8:4, pages 383-388.
Crossref
Toshitaka Nabeshima, Kazumasa Yamaguchi, Kiyofumi Yamada, Masayuki Hiramatsu, Hiroshi Furukawa & Tsutomu Kameyama. (1983) Phencyclidine-induced stereotyped behaviors in rats following specific neurotoxin lesions of the striatum. European Journal of Pharmacology 93:3-4, pages 229-234.
Crossref
Toshitaka Nabeshima, Kiyofumi Yamada, Kazumasa Yamaguchi, Masayuki Hiramatsu, Hiroshi Furukawa & Tsutomu Kameyama. (1983) Effect of lesions in the striatum. nucleus accumbens and medial raphe on phencyclidine-induced stereotyped behaviors and hyperactivity in rats. European Journal of Pharmacology 91:4, pages 455-462.
Crossref
A.S. Freeman & B.R. Martin. (1981) Quantification of Phencyclidine in Mainstream Smoke and Identification of Phenylcyclohex-1-ene as Pyrolysis Product. Journal of Pharmaceutical Sciences 70:9, pages 1002-1004.
Crossref
Margaret M. McCarron, Bernd W. Schulze, Gregory A. Thompson, Meta C. Conder & Walter A. Goetz. (1981) Acute phencyclidine intoxication: Clinical patterns, complications, and treatment. Annals of Emergency Medicine 10:6, pages 290-297.
Crossref
W. Marvin Davis, Ronald F. Borne, Robert B. Hackett & I.W. Waters. (1980) Lethal synergism of phencyclidine with a precursor and contaminant, 1-piperidinocyclohexanecarbonitrile. Life Sciences 26:24, pages 2105-2111.
Crossref
Z. E. HeveranM. AnthonyC. Ward. (1980) Determination of Phencyclidine by Radioimmunoassay. Journal of Forensic Sciences 25:1, pages 10940J.
Crossref
R. David Sturgeon, Richard G. Fessler & Herbert Y. Meltzer. (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotypes behavior and ataxia in rats. European Journal of Pharmacology 59:3-4, pages 169-179.
Crossref
Mark L. Richards, Paul J. Perry & Barry I. Liskow. (2016) Phencyclidine Psychosis. Drug Intelligence & Clinical Pharmacy 13:6, pages 336-339.
Crossref
Richard T. Rappolt, George R. Gay & R. David Farris. (1979) Emergency management of acute phencyclidine intoxication. Journal of the American College of Emergency Physicians 8:2, pages 68-76.
Crossref
R. Stanley Burns & Steven E. Lerner. (1978) Phencyclidine deaths. Journal of the American College of Emergency Physicians 7:4, pages 135-141.
Crossref